Figure 5From: Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications In-vivo migration of BM-MSCs injected into the tail vein using 26 G needle: (A) Represents control animal without cell injection; (B) Indicates migration pattern of BM-MSCs after 30 minutes; (C) Represents grater migration ability of BM-MSCs after 24 hours of implantation. Back to article page